Your session is about to expire
← Back to Search
TMS for Cerebellar Ataxia
Study Summary
This trial will study if people with cerebellar degeneration can learn better with brain stimulation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am cleared to receive brain stimulation treatment.I have unusual movements or symptoms like Parkinson's.I can understand and follow instructions without any cognitive issues.You have a history of drinking too much alcohol or using illegal drugs.I experience numbness or loss of sensation in my arms.My vision is normal or corrected to normal with glasses or contacts.My hearing is normal or corrected to normal.I have been diagnosed with cerebellar ataxia due to cerebellar degeneration.I have an injury or pain in my arms.
- Group 1: rTMS Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies for potential participants in this clinical trial?
"Indeed, according to clinicaltrials.gov the trial is recruiting participants as of this moment in time. The initial post was published on July 1st 2022 and recently updated on July 18th 2022. Only 12 patients are needed across one medical centre for enrollment into the study."
Are there any restrictions as to who can participate in this experiment based on age?
"This trial is accepting applicants who are aged 18 or above and below the age of 80."
What is the target recruitment for this investigation?
"Affirmative. The details of this study, which was initially posted on July 1st 2022 and updated most recently on the 18th of July, are currently available to view on clinicaltrials.gov. 12 individuals need to be admitted from a single site in order for the trial to reach completion."
Does this clinical trial have eligibility criteria that potential participants must meet?
"For this clinical trial, 12 people with hypermetria who are aged between 18 and 80 will be admitted. To qualify for the study, applicants must have a diagnosis of cerebellar ataxia from cerebellar degeneration as well as regular vision and hearing capabilities; moreover, they need to fulfil safety standards required for transcranial magnetic stimulation treatments."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger